A Transparency Market Research report on the global spine biologics market showed minimal pain and invasiveness drive surgeons' increasing preference for spine biologics. The market is dominated by North America because of factors including medical literacy and growing per capita income, while an expanding population and improving medical technology will drive significant growth in the Asia-Pacific market.
Report: Worldwide spine biologics market poised to expand
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.